FRE — Fresenius SE & Co KGaA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Fresenius SE & Co KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35,409	36,277	37,520	21,532	22,299
Cost of Revenue
Gross Profit	10,348	10,316	10,311	5,403	5,058
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30,778	31,892	33,362	19,720	21,156
Operating Profit	4,631	4,385	4,158	1,812	1,143
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	3,912	3,726	3,652	1,597	715
Provision for Income Taxes
Net Income After Taxes	3,029	2,823	2,819	1,222	238
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,883	1,707	1,818	1,372	-594
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,883	1,707	1,818	1,372	-594
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.55	3.35	2.63	2.33	2.1
Dividends per Share